251
Keros Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
286
FY23:
347
FY24:
589
FY25:
315
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.81
FY22:
21.0
FY23:
22.7
FY24:
27.0
FY25:
22.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
255
FY22:
307
FY23:
370
FY24:
616
FY25:
338
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
16.5
FY23:
24.4
FY24:
27.5
FY25:
20.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.23
FY22:
12.8
FY23:
13.4
FY24:
16.9
FY25:
14.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
243
FY22:
277
FY23:
332
FY24:
572
FY25:
303
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
255
FY22:
307
FY23:
370
FY24:
616
FY25:
338
All amounts in millions USD